Cited by 158Infective Endocarditis Diagnosis and ManagementStreptococcal Infections and TreatmentsGut microbiota and health

The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease

Boleij, Annemarie, Tjalsma, Harold·2013·The Lancet Infectious Diseases

Abstract

Bacteria constitute about 90% of all cells in the human body. The densest and most complex bacterial community is in the large intestine. This population is quite stable in healthy intestines, but intestinal disease distorts the ecological balance and induces dysbiosis. Results of studies have indicated that the epithelial and metabolic changes that occur with colorectal cancer provide a competitive advantage to a subset of intestinal bacteria. Strikingly, however, Streptococcus gallolyticus gallolyticus (previously known as Streptococcus bovis biotype I) is one of the very few opportunistic pathogens that has been clinically linked to colonic malignant diseases. In this Personal View we describe how S. gallolyticus gallolyticus exploits its unique range of virulence features to cause infections in patients with colorectal cancer. We postulate that distinct virulence factors on one hand enable this bacterium to establish a symptomatic infection in susceptible individuals, and on the other hand make its ability to do this dependent on pre-existing colonic abnormalities. We believe that our current reconstruction of this route of infection aids understanding of how S. gallolyticus gallolyticus infections can be best exploited for early detection of colorectal cancer.

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(13)70107-5

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • As colorectal cancer develops, epithelial and metabolic shifts could give some gut bacteria a competitive edge.

    “The epithelial and metabolic changes that occur during development of CRC might provide a competitive advantage to a subset of intestinal bacteria.185”
  • A small number of specific pathobionts have now been linked with adenomas and colorectal cancer, including Streptococcus gallolyticus, Enterococcus faecalis and B. fragilis.

    “a small number of specific pathobionts have now been linked with adenomas and CRC including Streptococcus gallolyticus,94 Enterococcus faecalis95 and B. fragilis.84”

    From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [94]

Cites

Flagged first, then by citations

1 of the 78 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Boleij, A., & Tjalsma, H.
Affiliations
  • Johns Hopkins University (US)
  • Radboud University Nijmegen (NL)
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2013-08
Volume
13
Issue
8
Pages
719-724
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2109510012
Cited by
158
References
78
Citations by year
2026: 9 · 2025: 9 · 2024: 12 · 2023: 16 · 2022: 14 · 2021: 9 · 2020: 13 · 2019: 15 · 2018: 9 · 2017: 16 · 2016: 11 · 2015: 10 · 2014: 14 · 2013: 1
FWCI
8.71
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
colorectal cancer, opportunistic infections, virulence factors, gut dysbiosis, gut microbiota, colorectal cancer detection, infection route, host-pathogen interaction
MeSH terms
Adenoma, Carcinoma, Endocarditis, Humans, Streptococcal Infections, Colorectal Neoplasms, Streptococcus bovis, Bacterial Translocation, Virulence Factors, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review